LABCORP HOLDINGS INC. Dividends Paid
LABCORP HOLDINGS INC. (LH) reported Dividends Paid of $119.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2026-08-05
- LABCORP HOLDINGS INC. payments of dividends for the quarter ending 2026-06-30 was $58.70M, a 2.00% decline year-over-year.
- LABCORP HOLDINGS INC. payments of dividends for the quarter ending 2026-03-31 was $61.20M, a 0.65% decline year-over-year.
- LABCORP HOLDINGS INC. payments of dividends for the quarter ending 2025-12-31 was $59.30M, a 1.33% decline year-over-year.
- LABCORP HOLDINGS INC. payments of dividends for the quarter ending 2025-09-30 was $59.90M, a 0.99% decline year-over-year.
- LABCORP HOLDINGS INC. payments of dividends for fiscal 2025 was $240.70M, a 0.99% decline from fiscal 2024.
- LABCORP HOLDINGS INC. payments of dividends for fiscal 2024 was $243.10M, a 4.29% decline from fiscal 2023.
- LABCORP HOLDINGS INC. payments of dividends for fiscal 2023 was $254.00M, a 30.12% increase from fiscal 2022.
- LABCORP HOLDINGS INC. payments of dividends for fiscal 2022 was $195.20M.
| Period end | Payments of Dividends 3 month | Payments of Dividends 6 month | Payments of Dividends 9 month | Payments of Dividends 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $119.90M 10-Q · filed 2026-08-05 | $179.20M derived: sum of 3 quarters · filed 2026-08-05 | $239.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $61.20M 10-Q · filed 2026-05-04 | $120.50M derived: sum of 2 quarters · filed 2026-05-04 | $180.40M derived: sum of 3 quarters · filed 2026-05-04 | $240.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $59.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $119.20M derived: sum of 2 quarters · filed 2026-02-24 | $179.10M derived: sum of 3 quarters · filed 2026-08-05 | $240.70M 10-K · filed 2026-02-24 |
| 2025-09-30 | $59.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $119.80M derived: sum of 2 quarters · filed 2026-08-05 | $181.40M 10-Q · filed 2025-10-31 | $241.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $59.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $121.50M 10-Q · filed 2026-08-05 | $181.60M derived: sum of 3 quarters · filed 2026-08-05 | $242.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $61.60M 10-Q · filed 2026-05-04 | $121.70M derived: sum of 2 quarters · filed 2026-05-04 | $182.20M derived: sum of 3 quarters · filed 2026-05-04 | $242.60M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $60.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $120.60M derived: sum of 2 quarters · filed 2026-02-24 | $181.00M derived: sum of 3 quarters · filed 2026-02-24 | $243.10M 10-K · filed 2026-02-24 |
| 2024-09-30 | $60.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $120.90M derived: sum of 2 quarters · filed 2025-10-31 | $183.00M 10-Q · filed 2025-10-31 | $244.10M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $60.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $122.50M 10-Q · filed 2025-08-01 | $183.60M derived: sum of 3 quarters · filed 2026-02-24 | $247.50M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $62.10M 10-Q · filed 2025-04-29 | $123.20M derived: sum of 2 quarters · filed 2026-02-24 | $187.10M derived: sum of 3 quarters · filed 2026-02-24 | $251.70M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $61.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $125.00M derived: sum of 2 quarters · filed 2026-02-24 | $189.60M derived: sum of 3 quarters · filed 2026-02-24 | $254.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | $63.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $128.50M derived: sum of 2 quarters · filed 2024-10-29 | $192.90M 10-Q · filed 2024-10-29 | $256.50M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $64.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $129.00M 10-Q · filed 2024-08-02 | $192.60M derived: sum of 3 quarters · filed 2025-02-25 | $257.50M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $64.40M 10-Q · filed 2024-04-30 | $128.00M derived: sum of 2 quarters · filed 2025-02-25 | $192.90M derived: sum of 3 quarters · filed 2025-02-25 | $259.60M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $63.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $128.50M derived: sum of 2 quarters · filed 2025-02-25 | $195.20M derived: sum of 3 quarters · filed 2025-02-25 | $195.20M 10-K · filed 2025-02-25 |
| 2022-09-30 | $64.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $131.60M derived: sum of 2 quarters · filed 2023-10-30 | $131.60M 10-Q · filed 2023-10-30 | |
| 2022-06-30 | $66.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $66.70M 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |